Bereich
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin
AIM · Dept. I
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
August-Jörg B, Renner E, Weitz M, Meyenberger C, Hermann R, Henz S, Gonvers J, Dufour J, Borovicka J, Swiss Association for the Study of the Liver. Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60.
23.08.2003Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
23.08.2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60
August-Jörg Barbara S E, Renner Eberhard L, Weitz Manfred, Meyenberger Christa, Hermann Rudolf, Henz Samuel, Gonvers Jean-Jacques, Dufour Jean-François, Borovicka Jan, Swiss Association for the Study of the Liver
The direct medical cost of type 2 diabetes
Brändle M, Zhou H, Smith B, Marriott D, Burke R, Tabaei B, Brown M, Herman W. The direct medical cost of type 2 diabetes. Diabetes care 2003; 26:2300-4.
01.08.2003The direct medical cost of type 2 diabetes
01.08.2003Diabetes care 2003; 26:2300-4
Brändle Michael, Zhou Honghong, Smith Barbara R K, Marriott Deanna, Burke Ray, Tabaei Bahman P, Brown Morton B, Herman William H
Extensive spherical amyloid deposition presenting as a pituitary tumor
Wiesli P, Brändle M, Brandner S, Kollias S, Bernays R. Extensive spherical amyloid deposition presenting as a pituitary tumor. Journal of endocrinological investigation 2003; 26:552-5.
01.06.2003Extensive spherical amyloid deposition presenting as a pituitary tumor
01.06.2003Journal of endocrinological investigation 2003; 26:552-5
Wiesli P, Brändle Michael, Brandner S, Kollias S S, Bernays R L
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
Brändle M, Davidson M, Schriger D, Lorber B, Herman W. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes care 2003; 26:1796-801.
01.06.2003Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes
01.06.2003Diabetes care 2003; 26:1796-801
Brändle Michael, Davidson Mayer B, Schriger David L, Lorber Brett, Herman William H
Impact of thyroid dysfunction on serum cystatin C
Fricker M, Wiesli P, Brändle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney international 2003; 63:1944-7.
01.05.2003Impact of thyroid dysfunction on serum cystatin C
01.05.2003Kidney international 2003; 63:1944-7
Fricker Manuel, Wiesli Peter, Brändle Michael, Schwegler Beat, Schmid Christoph
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
Hernan W, Brändle M, Zhang P, Williamson D, Matulik M, Ratner R, Lachin J, Engelgau M, Diabetes Prevention Program Research Group. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes care 2003; 26:36-47.
01.01.2003Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
01.01.2003Diabetes care 2003; 26:36-47
Hernan William H, Brändle Michael, Zhang Ping, Williamson David F, Matulik Margaret J, Ratner Robert E, Lachin John M, Engelgau Michael M, Diabetes Prevention Program Research Group
A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
Wiesli P, Brändle M, Schwegler B, Lehmann R, Spinas G, Schmid C. A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. Journal of internal medicine 2002; 252:504-9.
01.12.2002A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast
01.12.2002Journal of internal medicine 2002; 252:504-9
Wiesli P, Brändle Michael, Schwegler B, Lehmann R, Spinas G A, Schmid C
Valuing health-related quality of life in diabetes
Coffey J, Brändle M, Zhou H, Marriott D, Burke R, Tabaei B, Engelgau M, Kaplan R, Herman W. Valuing health-related quality of life in diabetes. Diabetes care 2002; 25:2238-43.
01.12.2002Valuing health-related quality of life in diabetes
01.12.2002Diabetes care 2002; 25:2238-43
Coffey J Todd, Brändle Michael, Zhou Honghong, Marriott Deanna, Burke Ray, Tabaei Bahman P, Engelgau Michael M, Kaplan Robert M, Herman William H
[Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases]
Vavricka S, Walter R, Brändle M, Ballmer P, Haller A. [Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases]. Deutsche medizinische Wochenschrift (1946) 2002; 127:2441-6.
15.11.2002[Diabetic ketoacidosis and hyperosmolar hyperglycemia. 24 consecutive cases]
15.11.2002Deutsche medizinische Wochenschrift (1946) 2002; 127:2441-6
Vavricka S R, Walter R B, Brändle Michael, Ballmer P E, Haller A
[Management of cardiovascular risk factors in type 2 diabetes mellitus]
Brändle M, Spinas G. [Management of cardiovascular risk factors in type 2 diabetes mellitus]. Therapeutische Umschau. Revue thérapeutique 2002; 59:415-21.
01.08.2002[Management of cardiovascular risk factors in type 2 diabetes mellitus]
01.08.2002Therapeutische Umschau. Revue thérapeutique 2002; 59:415-21
Brändle Michael, Spinas G A
Massive Leberverkalkung und verkalkte Weichteilmetastasen bei kolorektalem Carcinom
Diethelm M, Kluckert J, Cerny T. Massive Leberverkalkung und verkalkte Weichteilmetastasen bei kolorektalem Carcinom. Swiss Medical Forum 2002; 10:241-242.
01.01.2002Massive Leberverkalkung und verkalkte Weichteilmetastasen bei kolorektalem Carcinom
01.01.2002Swiss Medical Forum 2002; 10:241-242
Diethelm Markus, Kluckert Jörg-Thomas, Cerny Thomas
Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours
Brändle M, Pfammatter T, Spinas G, Lehmann R, Schmid C. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clinical endocrinology 2001; 55:357-62.
01.09.2001Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours
01.09.2001Clinical endocrinology 2001; 55:357-62
Brändle Michael, Pfammatter T, Spinas G A, Lehmann R, Schmid C
Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation
Brändle M, Lehmann R, Maly F, Schmid C, Spinas G. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes care 2001; 24:1253-8.
01.07.2001Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation
01.07.2001Diabetes care 2001; 24:1253-8
Brändle Michael, Lehmann R, Maly F E, Schmid C, Spinas G A
10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods
Clerici T, Schmid C, Komminoth P, Lange J, Spinas G, Brändle M. 10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:381-6.
30.06.200110 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods
30.06.2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:381-6
Clerici Thomas, Schmid C, Komminoth P, Lange Jochen, Spinas G A, Brändle Michael
Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose
Imhof A, Schneemann M, Schaffner A, Brändle M. Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:81-3.
10.02.2001Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose
10.02.2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:81-3
Imhof A, Schneemann M, Schaffner A, Brändle Michael
[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
Brändle M, Schlaeppi M, Schmid C. [Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]. Schweiz Med Wochenschr 2000; 130:861.
03.06.2000[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
03.06.2000Schweiz Med Wochenschr 2000; 130:861
Brändle Michael, Schlaeppi Marc, Schmid C
Galactorrhoea and pituitary mass: a typical prolactinoma?
Brändle M, Schmid C. Galactorrhoea and pituitary mass: a typical prolactinoma?. Postgraduate medical journal 2000; 76:232-4.
01.04.2000Galactorrhoea and pituitary mass: a typical prolactinoma?
01.04.2000Postgraduate medical journal 2000; 76:232-4
Brändle Michael, Schmid C
[Yellow nail syndrome]
Köberle D, Henz S, Flury D, Mayer R. [Yellow nail syndrome]. Schweizerische medizinische Wochenschrift 1999; 129:1342.
18.09.1999[Yellow nail syndrome]
18.09.1999Schweizerische medizinische Wochenschrift 1999; 129:1342
Köberle Dieter, Henz Samuel, Flury D, Mayer R
Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome
Kleinle S, Henz S, Krähenbühl S. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome. J Hepatol 1999; 31:550-555.
01.09.1999Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome
01.09.1999J Hepatol 1999; 31:550-555
Kleinle Stefanie, Henz Samuel, Krähenbühl Stefan
[Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]
Eggenberger C, Brändle M, Galeazzi R, Spinas G, Schmid C. [Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]. Schweizerische medizinische Wochenschrift 1999; 129:890-5.
12.06.1999[Cushing syndrome due to ectopic ACTH secretion: an uncommon case presentation, diagnosis and therapy]
12.06.1999Schweizerische medizinische Wochenschrift 1999; 129:890-5
Eggenberger C, Brändle Michael, Galeazzi R L, Spinas G A, Schmid C